SCHEMBL4042966

SCHEMBL4042966

Cc1ncn(-c2ccccc2CNC(=O)c2nc3n(c(=O)c2OCc2ccccc2)CCOC3(C)C)n1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE9A O76083 1/20 0.33
F2 P00734 2/20 0.33
GRM5 P41594 1/20 0.31
ALDH1A1 P00352 3/20 0.31
POLB P06746 2/20 0.31
PKM P14618 1/20 0.31
THRB P10828 1/20 0.31
PTGER1 P34995 1/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
SETDB1 Q15047 1/20 0.31
GAA P10253 1/20 0.31
PIK3CD O00329 1/20 0.31
PSEN1 P49768 1/20 0.31
PSEN2 P49810 1/20 0.31
APH1B Q8WW43 1/20 0.31
NCSTN Q92542 1/20 0.31
APH1A Q96BI3 1/20 0.31
PSENEN Q9NZ42 1/20 0.31
RIPK1 Q13546 1/20 0.31
KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4041831 0.92 POLB (0.32) POLBTHRBPTGER1RIPK1
SCHEMBL4037294 0.88 MYC (0.35) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5621796 0.87 LIPG (0.36) PDE9AF2ALDH1A1THRBSETDB1
SCHEMBL4036689 0.86 APOBEC3A (0.34) GRM5ALDH1A1POLBPKMTHRB
SCHEMBL4041061 0.85 F2 (0.37) F2GRM5ALDH1A1POLBPKM
SCHEMBL4034903 0.85 NAAA (0.36) GRM5ALDH1A1POLBPKMKDM4E
SCHEMBL1169632 0.82 METAP2 (0.40) GRM5ALDH1A1POLBPKMTHRB
SCHEMBL14511038 0.81 L3MBTL1 (0.36) ALDH1A1PKML3MBTL1RIPK1
SCHEMBL4037563 0.81 ADORA2A (0.34) ALDH1A1L3MBTL1PDE5A
SCHEMBL4039718 0.81 MEN1 (0.35) L3MBTL1PDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7491819-B1 N-[4-Fluorophenyl)methyl]-4,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide as an HIV integrase inhibitor BRISTOL-MYERS SQUIBB COMPANY (US) 2009-02-17 US disclosed
US-7491819-B1 N-[4-Fluorophenyl)methyl]-4,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide as an HIV integrase inhibitor BRISTOL-MYERS SQUIBB COMPANY (US) 2009-02-17 US disclosed
US-7491819-B1 N-[4-Fluorophenyl)methyl]-4,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide as an HIV integrase inhibitor BRISTOL-MYERS SQUIBB COMPANY (US) 2009-02-17 US disclosed
WO-2007064316-A1 BICYCLIC HETEROCYCLES AS HIV INTEGRASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-06-07 WO disclosed
US-7157447-B2 Bicyclic heterocycles as HIV integrase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-01-02 US disclosed
US-7157447-B2 Bicyclic heterocycles as HIV integrase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-01-02 US disclosed
US-7157447-B2 Bicyclic heterocycles as HIV integrase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-01-02 US disclosed